AVCR.V - Avricore Health Inc.
| Previous Close | 0.2750 |
| Open | 0.2750 |
| Bid | 0.2750 x 0 |
| Ask | 0.2800 x 0 |
| Day's Range | 0.2750 - 0.2850 |
| 52 Week Range | 0.1150 - 0.4100 |
| Volume | |
| Avg. Volume | 37,291 |
| Market Cap | 27.12M |
| Beta (5Y Monthly) | -2.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | May 02, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireAvricore Grants Options
VANCOUVER, British Columbia, May 15, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 1,625,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.28 per common share. All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the app
- GlobeNewswire
Avricore Health Corporate Updates on Audited Results for 2022
The Company will host an investor update call on May 3rd with CEO Hector Bremner to share the Company’s outlook and take questionsVANCOUVER, British Columbia, May 02, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today is pleased to announce its audited final results for 2022. The Company achieved record revenues of over $1.75 million while it also continues to narrow the gap to net profitability, clearly demonstrating stellar fiscal management during a tim
- News Direct
Avricore Health announces company’s HealthTab is now in over 530 locations
Avricore Health CEO Hector Bremner joined Steve Darling from Proactive to share news the company has hit another major milestone with its HealthTab network of pharmacy locations now reaching 532 lo...
- GlobeNewswire
Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching 532 locations. In 100 of these locations, the Company will be deploying Abbott’s ID Now™, either in combination with the Afinion 2™ or standalone, to support virus detection and assess the demand and effectiveness of infectious disease screening in community pharmacies. “We are seeing significant deman
- GlobeNewswire
Avricore Health Makes the Grade on 2023 TSX Venture 50
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX Venture Exchange’s list of top performing companies. “To make the Venture 50 feels great and the whole team is excited to keep delivering on our promise to build the world’s largest rapid-testing network in pharmacy,” said Hector Bremner, CEO of Avricore Health. “Thank you to all our partners and support
- News Direct
Avricore Health looks to continue positive growth in 2023 after success in 2022
Avricore Health CEO Hector Bremner joined Proactive's Steve Darling with an update on the company's 2022 performance and the goals it has set for 2023.
- GlobeNewswire
Avricore Health Corporate Update – Earnings Advisory 2022 and 2023 Objectives
VANCOUVER, British Columbia, Feb. 01, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world. As part of this effort the Company is pleased to provide insight into the successes of last year and lay out updates and objectives on further progress. “Last year we set out bold targe
- Baystreet
Atlas, Avricare, Brunswick at 52-Week Highs
Atlas Engineered Products Ltd. (V.AEP) hit a new 52-week high of 75 cents Monday. No news stories available ...
- GlobeNewswire
Avricore Health Reports Third-Quarter 2022 Results
VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today released its Q3 results which demonstrate significant revenue growth, indicating it can scale sustainably and deliver on its long-term objectives. The Company’s objective to create the world’s first cloud-connected point-of-care network in community pharmacy is on track to becoming a reality, bringing powerful health screening and data management tools to community pha
- Baystreet
CP, Avricore at 52-Week Highs
Canadian Pacific Railway Limited (T.CP) hit a new 52-week high of $109.49 Friday. No news stories available ...
GlobeNewswirePresenting on the Emerging Growth Conference on October 26 Register Now
Niche Companies in, Technology, Transportation, Biotech, Mining, MedTech, Logistics, and HealthcareMIAMI, Oct. 25, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 43rd Emerging Growth Conference on October 26, 2022. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong manageme
- GlobeNewswire
Avricore to Present at Emerging Growth Conference on Oct. 26, 2022
VANCOUVER, British Columbia, Oct. 21, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is excited to present at the Emerging Growth Conference on October 26th. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Hector Bremner in real time on the Company’s current activities. After a short presentation, the floor will be subsequently opened for questions, where Mr.
- GlobeNewswire
HealthTab™ Roll Out on Track and Operations Cashflow Positive
VANCOUVER, British Columbia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to provide this corporate update on the Company’s execution expanding its powerful chronic-disease screening and reporting platform, HealthTab. On August 8th, the Company announced a new Master Service Agreement and Statement of Work was signed with Shoppers Drug Mart pharmacies to significantly expand the HealthTab point-of-care testing platform to up to 450 loca
- GlobeNewswire
Avricore Health Announces CEO Update Call on Sept. 22, 2022
VANCOUVER, British Columbia, Sept. 20, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is excited to offer a live discussion on the Company’s current activities and forward outlook as it executes a significant national scale-up of its pharmacy-based point-of-care platform, HealthTab. “We’re currently deploying a significant expansion of HealthTab systems and we’re on track to achieve our revenue goals, as well as getting to cash flow positivity,” said Avricor
- GlobeNewswire
Avricore Health Supports the Globe and Mail’s Health Innovation Event
VANCOUVER, British Columbia , Sept. 19, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) was honoured to join the Globe and Mail’s recent Health Care Innovation event, featuring leaders from various corners of the sector, including Company CEO, Hector Bremner. “With about 40% of patients in Canada saying it’s difficult to access a diagnostics test and nine million expressing difficulty in getting access to care, it’s clear that the time is now to support more
- GlobeNewswire
Avricore Health Reports Second-Quarter 2022 Results
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. “We have now begun a new era for Healthtab™ and the Company as we expand Shoppers Drug Mart significantly over the coming weeks,” said Hector Bremner, CEO of Avricore Health Inc. “We are now realizing our revenue targets and are on track to realize long-term profitability as we continue to successfully
- GlobeNewswire
Healthtab™ Expands With Shoppers Drug Mart®
VANCOUVER, British Columbia, Aug. 08, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce that the Company is significantly expanding the number of Shoppers Drug Mart pharmacies offering its HealthTab point-of-care testing platform under a renewed Master Service Agreement (MSA) to up to 450 locations nation-wide. In addition to Shoppers Drug Mart pharmacies, this new MSA and corresponding Statement of Work (SOW) provides for affiliated loca
- GlobeNewswire
Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
VANCOUVER, British Columbia, June 02, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s activities and progress in the first five months of 2022, as well as an outlook on the Company’s objectives and expectations for the balance of the year. “At the beginning of the year, we laid out a plan to expand our point-of-care testing platform in pharmacies across Canada and beyond and begin to generate more s